Quick Answer
Tempest Therapeutics, Inc. reported Total Revenue of $295.0 thousand for the year ending 2017.
- Tempest Therapeutics, Inc. showed a decrease of -54.8% in Total Revenue from 2016 to 2017.
- This data is from Tempest Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 15, 2018.
- XBRL data for this metric is available from 2013 to 2017 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $0.00 | Q3 2014: $0.00 | Q1 2015: $15.0 thousand | Q2 2015: $30.0 thousand | Q3 2015: $75.0 thousand | Q1 2016: $146.0 thousand | Q2 2016: $189.0 thousand | Q3 2016: $197.0 thousand | Q1 2017: $63.0 thousand | Q2 2017: $84.0 thousand | Q2 2017: $84.0 thousand | Q3 2017: $56.0 thousand | Q3 2017: $56.0 thousand | Q1 2018: $67.0 thousand | Q2 2018: $81.0 thousand | Q3 2018: $55.0 thousand.
- Historical annual values: Fiscal year 2017: $295.0 thousand | Fiscal year 2016: $653.0 thousand | Fiscal year 2015: $277.0 thousand | Fiscal year 2014: $0.00 | Fiscal year 2013: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: